IP Library Patent Application 13857882
Patent Application
App. No. 13/857,882

STABLE FORMULATIONS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/857,882
Abstract

Described herein are aqueous formulations with stabilized reactive and/or radical species.

Claims (30)

1 . An aqueous formulation comprising:

an electrolyzed saline solution housed in a non-reactive container, wherein the electrolyzed saline solution includes at least one superoxide radical that is greater than about 60% stable for at least 1 year.

2 . The aqueous formulation of claim 1 , wherein the non-reactive container is formed of polyethylene, polypropylene, polystyrene, or borosilicate glass.

3 . The aqueous formulation of claim 1 , wherein the non-reactive container is formed of borosilicate glass.

4 . The aqueous formulation of claim 3 , wherein the at least one superoxide radical has a half-life of about 24 years.

5 . The aqueous formulation of claim 3 , wherein the at least one superoxide radical has a half-life of greater than about 24 years.

6 . The aqueous formulation of claim 3 , wherein the at least one superoxide radical is greater than about 98% stable for at least 1 year.

7 . The aqueous formulation of claim 3 , wherein the at least one superoxide radical is greater than about 79% stable for at least 6 years.

8 . The aqueous formulation of claim 3 , wherein the at least one superoxide radical is greater than about 72% stable for at least 8 years.

9 . The aqueous formulation of claim 3 , wherein the at least one superoxide radical is greater than about 65% stable for at least 10 years.

10 . The aqueous formulation of claim 3 , wherein the at least one superoxide radical is 100% stable for at least 20 years.

11 . The aqueous formulation of claim 1 , wherein the electrolyzed saline solution includes the at least one superoxide radical and at least one hypochlorite.

12 . The aqueous formulation of claim 1 , wherein the electrolyzed saline solution is a product of a circulating solution having a salt concentration of between about 10.00 g NaCl/gal and about 12.00 g NaCl/gal and wherein the circulating solution is electrolyzed using a set of electrodes with an amperage of between about 50 amps and about 60 amps.

13 . The aqueous formulation of claim 12 , wherein the circulating solution has a temperature of about 4.5° C. to about 5.8° C.

14 . A method of making an aqueous formulation comprising:

electrolyzing a circulating solution having a salt concentration of between about 10.00 g NaCl/gal and about 12.00 g NaCl/gal using a set of electrodes with a voltage greater than about 2.6 mV and an amperage of between about 50 amps and about 60 amps thereby forming an electrolyzed saline solution; and

placing the electrolyzed saline solution into a non-reactive container,

wherein the electrolyzed saline solution includes at least one oxygen radical that is greater than about 95% stable for at least 1 year within the non-reactive container.

15 . The method of claim 14 , wherein the non-reactive container is formed borosilicate glass.

16 . The method of claim 14 , wherein the oxygen radical is a superoxide.

17 . The method of claim 16 , wherein the superoxide has a half-life of about 24 years.

18 . The method of claim 16 , wherein the electrolyzed saline solution includes the superoxide and at least one hypochlorite.

19 . The method of claim 14 , wherein the at least one oxygen radical is greater than about 98% stable for at least 1 year.

20 . The method of claim 14 , wherein the at least one oxygen radical is greater than about 79% stable for at least 6 years.

21 . The method of claim 14 , wherein the at least one oxygen radical is greater than about 72% stable for at least 8 years.

22 . The method of claim 14 , wherein the at least one oxygen radical is greater than about 65% stable for at least 10 years.

23 . The method of claim 14 , wherein the at least one oxygen radical is 100% stable for at least 20 years.

24 . The method of claim 14 , wherein the circulating solution has a temperature of about 4.5° C. to about 5.8° C.

25 . The method of claim 14 , wherein the aqueous formulation is administered to a mammal to treat a health condition.

26 . The method of claim 14 , wherein the aqueous formulation is administered to a mammal to enhance an athletic characteristic.

Assignments (3)
CHANGE OF NAME Recorded Jun 18, 2019
From: REOXCYN DISCOVERIES GROUP, INC.
To: RDG HOLDINGS, INC.
Reel/Frame 049511/0685 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2018
From: REOXCYN DISCOVERIES GROUP, INC.
To: REOXCYN INNOVATION GROUP, LLC
Reel/Frame 044783/0981 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2013
From: NORTON, VERDIS; SAMUELSON, GARY L.
To: REOXCYN DISCOVERIES GROUP, INC.
Reel/Frame 030286/0512 →